美国Parexel International
全球领先的生物制药服务公司PAREXEL International Corporation (NASDAQ:PRXL)
PAREXEL International公司是全球领先的生物制药服务公司，公司面向全球制药业、生物技术业以及医疗设备业提供广泛的基于知识的合同研究、医学交流和咨询服务。PAREXEL公司致力于提供可加快产品上市以及向高端市场渗透进程的解决方案，业已开发出了从药物开发和法规咨询到临床药理学、临床试验管理、医学教育和赔偿等开发和商业化整个系统领域的重要专门技术。PAREXEL公司的子公司Perceptive Informatics公司提供包括医学成像在内的先进技术解决方案，以加快临床开发进程。PAREXEL公司总部位于马萨诸塞州波士顿的郊区，在全球51个国家设立了64个业务点开展业务，公司拥有近7,000名员工。

Over the past 25 years, PAREXEL has developed significant expertise to assist clients in the worldwide pharmaceutical, biotechnology and medical device industries with the development and launch of their products in order to bring safe and effective treatments to the global marketplace for the patients who need them. Headquartered near Boston, Massachusetts, PAREXEL operates in 69 locations throughout 52 countries around the world, and has more than 9,250 employees.

We are a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.